We’re excited to announce that Enzo Biochem has been acquired by Battery Ventures, a technology-focused investment firm with deep expertise in both the technology and life sciences sectors. Enzo is now operating as a private company, enabling an enhanced focus and flexibility in serving our customers worldwide.  

This strategic move marks a new chapter for Enzo — one that strengthens our market position, fuels innovation, and ensures continued excellence in the quality products and services our customers have come to expect from us.

Veteran life science executive Jason Apter will lead Enzo as CEO. Mr. Apter previously served as CEO of Sannova Analytical, an organization offering bioanalytical and analytical testing services to pharmaceutical and biotech companies, as well as serving in senior leadership roles at MilliporeSigma and Johnson Matthey.


Your Questions Answered

Thank you for your continued business and trust. We deeply appreciate your ongoing partnership, and we’re excited to continue to serve you under the new leadership of Battery Ventures.

Leave a comment